PUBLISHER: The Business Research Company | PRODUCT CODE: 1713591
PUBLISHER: The Business Research Company | PRODUCT CODE: 1713591
Hydronephrosis Global Market Report 2025
Hydronephrosis is a medical condition marked by the swelling of one or both kidneys due to a buildup of urine. This swelling happens when urine flow is obstructed, leading to an enlarged kidney. The obstruction can be caused by factors such as kidney stones, tumors, or anatomical abnormalities, and if not treated, it may result in kidney damage.
Hydronephrosis can be classified into two main types such as unilateral and bilateral. Unilateral hydronephrosis occurs when one kidney swells due to a blockage or other issues in the urinary tract on that side. It can be further categorized as intrinsic or extrinsic. Diagnosis typically involves laboratory tests and imaging studies. Treatment options may include shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, among others.
The hydronephrosis market research report is one of a series of new reports from The Business Research Company that provides hydronephrosis market statistics, including hydronephrosis industry global market size, regional shares, competitors with a hydronephrosis market share, detailed hydronephrosis market segments, market trends and opportunities, and any further data you may need to thrive in the hydronephrosis industry. This hydronephrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hydronephrosis market size has grown rapidly in recent years. It will grow from $3.06 billion in 2024 to $3.38 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the increasing prevalence of kidney stones, rising incidence of urinary tract infections, growth in the geriatric population, increasing awareness and early diagnosis, and rising healthcare expenditure.
The hydronephrosis market size is expected to see rapid growth in the next few years. It will grow to $4.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the increasing prevalence of chronic kidney diseases, rising adoption of minimally invasive surgeries, growing awareness about early detection, expansion of healthcare infrastructure, and development of new treatment options. Major trends in the forecast period include growth in personalized medicine, increasing use of artificial intelligence in diagnostics, advancements in non-invasive treatment methods, rise in patient-centric healthcare approaches, and integration of telemedicine in nephrology.
The increasing prevalence of kidney diseases is anticipated to drive the growth of the hydronephrosis market in the future. Kidney disease, also referred to as renal disease or nephropathy, encompasses a variety of conditions that lead to kidney damage, hindering their ability to effectively filter blood. The surge in kidney disease cases can be attributed to multiple factors, including the growing rates of diabetes and hypertension, obesity, an aging population, and both genetic and ethnic influences. Treatment for hydronephrosis focuses on addressing the underlying causes of urinary obstruction, which may involve medications, surgical procedures, or other interventions to restore normal urine flow. For example, a report published in June 2023 by Kidney Research UK, a non-profit organization based in the UK, indicated that approximately 7.2 million people in the UK are currently living with chronic kidney disease, accounting for over 10% of the population. Among these individuals, 3.25 million are in the advanced stages of the disease, while another 3.9 million are in the early stages. By 2033, it is projected that the number of individuals affected by chronic kidney disease will increase to 7.61 million. Thus, the rising incidence of kidney diseases is fueling the growth of the hydronephrosis market.
Leading companies in the hydronephrosis market are creating innovative products like drainage catheters to improve patient care by offering efficient and minimally invasive solutions for urine drainage from the kidneys. Drainage catheters are medical devices designed to extract fluids, such as urine or blood, from the body to alleviate pressure or prevent fluid buildup. For example, in October 2024, Argon Medical Devices Inc., a U.S.-based manufacturer of specialized medical products, introduced the SKATER mini-loop drainage catheter. This device is specifically designed for the minimally invasive drainage of unwanted fluid collections within the body. It is inserted through the skin with imaging guidance and features a loop that is 40% smaller, ensuring secure placement and effective drainage from smaller cavities. Renowned for its durability, kink resistance, and compatibility with alcohol, this catheter enhances usability during interventional procedures. By expanding Argon's drainage product line, the SKATER Mini-Loop aims to improve patient outcomes and streamline the drainage process for healthcare professionals.
In October 2023, Laborie Medical Technologies Corp., a US-based diagnostic company, acquired Urotronic Inc. for an undisclosed amount. This acquisition strengthens Laborie's urology portfolio by providing innovative solutions to physicians and patients worldwide. It allows Laborie to advance cutting-edge technologies to address unmet medical needs and deliver solutions that uphold and restore human dignity. Urotronic Inc., a US-based medical device company, specializes in developing innovative treatments for urological conditions.
Major companies operating in the hydronephrosis market are AbbVie Inc., Boston Scientific Corporation, Novartis AG, 3M Company, F. Hoffmann-La Roche Ltd, Medtronic PLC, Amgen Inc., Stryker Corporation, Thermo Fisher Scientific Inc., B. Braun Group, Terumo Interventional Systems, Sigma-Aldrich Co, Coloplast A/S, Cook Medical, KARL STORZ SE & Co. KG, Spire Healthcare Group plc, Promega Corporation, NantHealth Inc., UroGen Pharma Ltd., Natus Medical Incorporated, Renal Associates P.A., Urologix Inc., Savant Medical Group
North America was the largest region in the hydronephrosis market in 2024. The regions covered in the hydronephrosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the hydronephrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hydronephrosis market includes revenues earned by entities by providing services such as urine flow monitoring, follow-up care, and minimally invasive procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hydronephrosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hydronephrosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hydronephrosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hydronephrosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Unilateral Hydronephrosis; Bilateral Hydronephrosis
- 2) By Indication: Intrinsic; Extrinsic
- 3) By Diagnosis: Laboratory Test; Imaging
- 4) By Treatment: Shock Wave Lithotripsy; Laparoscopy; Bladder Catheterization; Steroid Therapy; Other Treatments
- Subsegments:
- 1) By Unilateral Hydronephrosis: Congenital Unilateral Hydronephrosis; Acquired Unilateral Hydronephrosis; Obstructive Unilateral Hydronephrosis; Non-Obstructive Unilateral Hydronephrosis
- 2) By Bilateral Hydronephrosis: Congenital Bilateral Hydronephrosis; Acquired Bilateral Hydronephrosis; Obstructive Bilateral Hydronephrosis; Non-Obstructive Bilateral Hydronephrosis
- Companies Mentioned: AbbVie Inc.; Boston Scientific Corporation; Novartis AG; 3M Company; F. Hoffmann-La Roche Ltd
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hydronephrosis Market Characteristics
3. Hydronephrosis Market Trends And Strategies
4. Hydronephrosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Hydronephrosis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Hydronephrosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Hydronephrosis Market Growth Rate Analysis
- 5.4. Global Hydronephrosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Hydronephrosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Hydronephrosis Total Addressable Market (TAM)
6. Hydronephrosis Market Segmentation
- 6.1. Global Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Unilateral Hydronephrosis
- Bilateral Hydronephrosis
- 6.2. Global Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Intrinsic
- Extrinsic
- 6.3. Global Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Laboratory Test
- Imaging
- 6.4. Global Hydronephrosis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Shock Wave Lithotripsy
- Laparoscopy
- Bladder Catheterization
- Steroid Therapy
- Other Treatments
- 6.5. Global Hydronephrosis Market, Sub-Segmentation Of Unilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Congenital Unilateral Hydronephrosis
- Acquired Unilateral Hydronephrosis
- Obstructive Unilateral Hydronephrosis
- Non-Obstructive Unilateral Hydronephrosis
- 6.6. Global Hydronephrosis Market, Sub-Segmentation Of Bilateral Hydronephrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Congenital Bilateral Hydronephrosis
- Acquired Bilateral Hydronephrosis
- Obstructive Bilateral Hydronephrosis
- Non-Obstructive Bilateral Hydronephrosis
7. Hydronephrosis Market Regional And Country Analysis
- 7.1. Global Hydronephrosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Hydronephrosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Hydronephrosis Market
- 8.1. Asia-Pacific Hydronephrosis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Hydronephrosis Market
- 9.1. China Hydronephrosis Market Overview
- 9.2. China Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Hydronephrosis Market
- 10.1. India Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Hydronephrosis Market
- 11.1. Japan Hydronephrosis Market Overview
- 11.2. Japan Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Hydronephrosis Market
- 12.1. Australia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Hydronephrosis Market
- 13.1. Indonesia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Hydronephrosis Market
- 14.1. South Korea Hydronephrosis Market Overview
- 14.2. South Korea Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Hydronephrosis Market
- 15.1. Western Europe Hydronephrosis Market Overview
- 15.2. Western Europe Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Hydronephrosis Market
- 16.1. UK Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Hydronephrosis Market
- 17.1. Germany Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Hydronephrosis Market
- 18.1. France Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Hydronephrosis Market
- 19.1. Italy Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Hydronephrosis Market
- 20.1. Spain Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Hydronephrosis Market
- 21.1. Eastern Europe Hydronephrosis Market Overview
- 21.2. Eastern Europe Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Hydronephrosis Market
- 22.1. Russia Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Hydronephrosis Market
- 23.1. North America Hydronephrosis Market Overview
- 23.2. North America Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Hydronephrosis Market
- 24.1. USA Hydronephrosis Market Overview
- 24.2. USA Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Hydronephrosis Market
- 25.1. Canada Hydronephrosis Market Overview
- 25.2. Canada Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Hydronephrosis Market
- 26.1. South America Hydronephrosis Market Overview
- 26.2. South America Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Hydronephrosis Market
- 27.1. Brazil Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Hydronephrosis Market
- 28.1. Middle East Hydronephrosis Market Overview
- 28.2. Middle East Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Hydronephrosis Market
- 29.1. Africa Hydronephrosis Market Overview
- 29.2. Africa Hydronephrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Hydronephrosis Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Hydronephrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Hydronephrosis Market Competitive Landscape And Company Profiles
- 30.1. Hydronephrosis Market Competitive Landscape
- 30.2. Hydronephrosis Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4.3M Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
31. Hydronephrosis Market Other Major And Innovative Companies
- 31.1. Medtronic PLC
- 31.2. Amgen Inc.
- 31.3. Stryker Corporation
- 31.4. Thermo Fisher Scientific Inc.
- 31.5. B. Braun Group
- 31.6. Terumo Interventional Systems
- 31.7. Sigma-Aldrich Co
- 31.8. Coloplast A/S
- 31.9. Cook Medical
- 31.10. KARL STORZ SE & Co. KG
- 31.11. Spire Healthcare Group plc
- 31.12. Promega Corporation
- 31.13. NantHealth Inc.
- 31.14. UroGen Pharma Ltd.
- 31.15. Natus Medical Incorporated
32. Global Hydronephrosis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Hydronephrosis Market
34. Recent Developments In The Hydronephrosis Market
35. Hydronephrosis Market High Potential Countries, Segments and Strategies
- 35.1 Hydronephrosis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Hydronephrosis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Hydronephrosis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
- 250423_r33493_Hydronephrosis_GMR_2025
